Infected Mushroom

Since selling into the listing day pump (sorry) I've been waiting patiently for $1 MMED.

Daily RSI is now 50+ and showing bullish divergence.

Now that MMED has a new CEO, I have more faith in MMED to deliver useful therapeutics. A more telling bottom signal is the change of CFO; let's hope Mr. "Greenway" lives up to his name :)

mindmed.co/news/pres...f-financial-officer/

Operación cerrada: precio stop alcanzado

Comentarios:

While I believe in the power of psychedelics to assist with mental health issues, I do not expect this company will survive the test of time because they are focusing on LSD which carries massive negative side effects. There's a strong chance MMED with get sued into oblivion for giving test subjects HPPD (Hallucinogen Persisting Perception Disorder). Psychedelic drugs are a double-edged sword.

Furthermore, Kevin O'Leary is a trashcan of a human being and should not be trusted with anything.